Reuters logo
7 months ago
BRIEF-DBV Technologies completes enrollment phase IIa viaskin milk study for of pediatric eosinophilic esophagitis
February 3, 2017 / 7:20 AM / 7 months ago

BRIEF-DBV Technologies completes enrollment phase IIa viaskin milk study for of pediatric eosinophilic esophagitis

Feb 3 (Reuters) - DBV Technologies SA :

* DBV Technologies announces completion of enrollment of phase IIa study of viaskin milk for the treatment of pediatric eosinophilic esophagitis

* Results for SMILEE study are expected in first half of 2018 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below